Business Description
Boule Diagnostics AB
ISIN : SE0011231158
Total Employee Number:
183Compare
Compare
Traded in other countries / regions
BOUL.Sweden8BD.GermanyBOULs.UKBDABF.USA IPO Date
2011-06-27Description
Boule Diagnostics AB is a company operating in the diagnostics market. It is engaged in the development, manufacturing and marketing instruments and consumables for blood diagnostics. The systems are intended for small and medium-sized hospitals, clinics and laboratories within outpatient care. the company operating through two complementary business segments: Diagnostics and OEM CDS. Through its subsidiaries, the company operates in USA ,Asia, Eastern Europe, Latin America Western Europe and Africa / Middle East. The majority revenue is generated from Asia.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.08 | |||||
Equity-to-Asset | 0.37 | |||||
Debt-to-Equity | 1.29 | |||||
Debt-to-EBITDA | 10.67 | |||||
Interest Coverage | 1.54 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 0.85 | |||||
Beneish M-Score | -2.86 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -13.1 | |||||
3-Year EBITDA Growth Rate | -20 | |||||
3-Year EPS without NRI Growth Rate | 1.7 | |||||
3-Year FCF Growth Rate | 67.3 | |||||
3-Year Book Growth Rate | -28.7 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 52.18 | |||||
9-Day RSI | 60.11 | |||||
14-Day RSI | 59.74 | |||||
3-1 Month Momentum % | -11.25 | |||||
6-1 Month Momentum % | -36.45 | |||||
12-1 Month Momentum % | -65.23 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.06 | |||||
Quick Ratio | 0.75 | |||||
Cash Ratio | 0.09 | |||||
Days Inventory | 87.75 | |||||
Days Sales Outstanding | 95.93 | |||||
Days Payable | 39.84 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -17.16 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 42.31 | |||||
Operating Margin % | 6.1 | |||||
Net Margin % | -1.63 | |||||
EBITDA Margin % | 4.35 | |||||
FCF Margin % | 3.14 | |||||
OCF Margin % | 4.26 | |||||
ROE % | -4.63 | |||||
ROA % | -1.65 | |||||
ROC (Joel Greenblatt) % | 13.54 | |||||
ROCE % | 8.33 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 4.16 | |||||
PE Ratio without NRI | 28.36 | |||||
PS Ratio | 0.31 | |||||
PB Ratio | 0.86 | |||||
Price-to-Tangible-Book | 1.74 | |||||
Price-to-Free-Cash-Flow | 10.03 | |||||
Price-to-Operating-Cash-Flow | 7.36 | |||||
EV-to-EBIT | 16.88 | |||||
EV-to-Forward-EBIT | 43.93 | |||||
EV-to-EBITDA | 16.88 | |||||
EV-to-Forward-EBITDA | 13.02 | |||||
EV-to-Revenue | 0.73 | |||||
EV-to-Forward-Revenue | 0.78 | |||||
EV-to-FCF | 23.4 | |||||
Price-to-GF-Value | 0.53 | |||||
Price-to-Median-PS-Value | 0.15 | |||||
Price-to-Graham-Number | 1.48 | |||||
Earnings Yield (Greenblatt) % | 5.92 | |||||
FCF Yield % | 10.16 | |||||
Forward Rate of Return (Yacktman) % | 8.22 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Boule Diagnostics AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 478.4 | ||
| EPS (TTM) (kr) | -0.03 | ||
| Beta | 0.1703 | ||
| 3-Year Sharpe Ratio | -0.84 | ||
| 3-Year Sortino Ratio | -0.98 | ||
| Volatility % | 48.58 | ||
| 14-Day RSI | 59.74 | ||
| 14-Day ATR (kr) | 0.193377 | ||
| 20-Day SMA (kr) | 3.614 | ||
| 12-1 Month Momentum % | -65.23 | ||
| 52-Week Range (kr) | 3.09 - 10.6 | ||
| Shares Outstanding (Mil) | 38.83 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Boule Diagnostics AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Boule Diagnostics AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-10-23 | In 101 days | ||
| Third quarter earnings results for 2026 | 2026-10-23 | In 101 days | ||
| Second quarter earnings conference call for 2026 | 2026-07-17 | In 3 days | ||
| Second quarter earnings results for 2026 | 2026-07-17 | In 3 days | ||
| General meeting for 2026 | 2026-05-13 16:00 | 3.23 (-9.52%) | ||
| First quarter earnings conference call for 2026 | 2026-04-28 10:00 | 3.82 (-4.26%) | ||
| First quarter earnings results for 2026 | 2026-04-28 08:00 | 3.82 (-4.26%) | ||
| Annual report for 2025 | 2026-04-10 | 3.95 (+0.77%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-11 10:00 | 4.94 (-8.18%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-11 08:00 | 4.94 (-8.18%) |
Show
Entries
Boule Diagnostics AB Frequently Asked Questions
What is Boule Diagnostics AB(OSTO:BOUL)'s stock price today?
The current price of OSTO:BOUL is kr3.80. The 52 week high of OSTO:BOUL is kr10.60 and 52 week low is kr3.09.
When is next earnings date of Boule Diagnostics AB(OSTO:BOUL)?
The next earnings date of Boule Diagnostics AB(OSTO:BOUL) is 2026-07-17.
Does Boule Diagnostics AB(OSTO:BOUL) pay dividends? If so, how much?
Boule Diagnostics AB(OSTO:BOUL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Boule Diagnostics AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers